Menu
Back to User profile » Dr Chen-Hsiang Lee
Papers published by Dr Chen-Hsiang Lee:
Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice
Hung KT, Yang SC, Wu CK, Wang HM, Yao CC, Liang CM, Tai WC, Wu KL, Kuo YH, Lee CH, Chuah SK
Infection and Drug Resistance 2021, 14:1239-1246
Published Date: 25 March 2021
Relation between flomoxef minimum inhibitory concentrations and clinical outcomes of patients treated with flomoxef for Enterobacteriaceae bacteremia
Lee CH, Chen IL, Li CC, Chien CC
Infection and Drug Resistance 2018, 11:2471-2480
Published Date: 27 November 2018
Daptomycin versus teicoplanin for bloodstream infection due to methicillin-resistant Staphylococcus aureus with a high teicoplanin minimal inhibitory concentration ≥1.5 mg/L: a propensity score-based analysis
Tsai CY, Lee CH, Chen IL
Infection and Drug Resistance 2018, 11:2011-2020
Published Date: 26 October 2018
Platelet reactivity in diabetic patients with invasive Klebsiella pneumoniae liver abscess syndrome
Lee CH, Chuah SK, Tai WC, Chen IL
Infection and Drug Resistance 2018, 11:1669-1676
Published Date: 9 October 2018
Impact of teicoplanin maintenance dose and MIC values on the clinical outcomes of patients treated for methicillin-resistant Staphylococcus aureus bacteremia
Tsai CY, Lee CH, Chien CC, Chen IL
Infection and Drug Resistance 2018, 11:1205-1217
Published Date: 15 August 2018
Prediction of imipenem-resistant microorganisms among the nosocomial critically ill patients with Gram-negative bacilli septicemia: a simple risk score
Chen IL, Lee CH, Ting SW, Wang LY
Infection and Drug Resistance 2018, 11:283-293
Published Date: 1 March 2018
Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia
Lee C, Chen I, Li CC, Chien C
Infection and Drug Resistance 2018, 11:257-266
Published Date: 23 February 2018